Funding for this research was provided by:
Clinical Research Plan of SHCD (SHDC2020CR3054B)
Received: 12 January 2022
Accepted: 26 May 2022
First Online: 18 June 2022
: This controlled trial was approved by the Ethics Committee of the Shanghai Changzheng Hospital (No: 2020SL031) and registered in the Chinese Clinical Trial Register website (ExternalRef removed, ChiCTR2100052027, October 14, 2021). Written informed consent was obtained from all participants.
: All participants signed a document of informed consent.
: The authors declare that they have no competing interests.